Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunological Basis for Benralizumab Activity in Chronic Obstructive Pulmonary Disease (COPD)

NCT05273359 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT05273359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05273359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunological Basis for Benralizumab Activity in Chronic Obstructive Pulmonary Disease (COPD)
Lead sponsor
Temple University
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2023
Completion date
January 31, 2025
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)